p38 mitogen-activated protein kinase regulates canonical Wnt-β-catenin signaling by inactivation of GSK3β

Journal of Cell Science

Volumn 121, Issue 21, 2008, Pages 3598-3607

  Bikkavilli, Rama Kames ^a   Feigin, Michael E ^a   Malbon, Craig C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

catenin; Canonical pathway; Dishevelled; Frizzled; G protein; Lef Tcf; p38 MAPK; Primitive endoderm; Wnt

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; BETA CATENIN; DISHEVELLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LYMPHOID ENHANCER FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; T CELL FACTOR PROTEIN; WNT PROTEIN; WNT3A PROTEIN; DISHEVELLED PROTEINS; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDODERM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; GENE ACTIVATION; GENETIC EPISTASIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; METABOLISM; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BETA CATENIN; CELL LINE, TUMOR; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOGEN SYNTHASE KINASE 3; GTP-BINDING PROTEINS; HUMANS; MICE; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; WNT PROTEINS;

EID: 59149098536     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.032854     Document Type: Article

References (32)

1. Aghib, D. F. and McCrea, P. D. (1995). The E-cadherin complex contains the src substrate p120. Exp. Cell Res. 218, 359-369.
2. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R. and Birchmeier, W. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642.
3. Bhanot, P., Brink, M., Samos, C. H., Hsieh, J. C., Wang, Y., Macke, J. P., Andrew, D., Nathans, J. and Nusse, R. (1996). A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382, 225-230.
4. Bikkavilli, R. K., Feigin, M. E. and Malbon, C. C. (2008). G{alpha}o mediates WNTJNK signaling through Dishevelled 1 and 3, RhoA family members, and MEKK 1 and 4 in mammalian cells. J. Cell Sci. 121, 234-245.
5. Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M. and Gutkind, J. S. (2005). Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-betacatenin signaling axis. Science 310, 1504-1510.
6. Caverzasio, J. and Manen, D. (2007). Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells. Endocrinology 148, 5323-5330.
7. Chang, J., Sonoyama, W., Wang, Z., Jin, Q., Zhang, C., Krebsbach, P. H., Giannobile, W., Shi, S. and Wang, C. Y. (2007). Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J. Biol. Chem. 282, 30938-30948.
8. Cook, D., Fry, M. J., Hughes, K., Sumathipala, R., Woodgett, J. R. and Dale, T. C. (1996). Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C. EMBO J. 15, 4526-4536.
9. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
10. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R. and Lee, J. C. (1995). SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233.
11. Farr, G. H., 3rd, Ferkey, D. M., Yost, C., Pierce, S. B., Weaver, C. and Kimelman, D. (2000). Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J. Cell Biol. 148, 691-702.
12. Gao, Y. and Wang, H. Y. (2007). Inositol pentakisphosphate mediates Wnt/beta-catenin signaling. J. Biol. Chem. 282, 26490-26502.
13. Gao, Z. H., Seeling, J. M., Hill, V., Yochum, A. and Virshup, D. M. (2002). Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex. Proc. Natl. Acad. Sci. USA 99, 1182-1187.
14. Hildesheim, J., Salvador, J. M., Hollander, M. C. and Fornace, A. J., Jr (2005). Casein kinase 2- and protein kinase A-regulated adenomatous polyposis coli and beta-catenin cellular localization is dependent on p38 MAPK. J. Biol. Chem. 280, 17221-17226.
15. Katanaev, V. L., Ponzielli, R., Semeriva, M. and Tomlinson, A. (2005). Trimeric G protein-dependent frizzled signaling in Drosophila. Cell 120, 111-122.
16. Keren, A., Bengal, E. and Frank, D. (2005). p38 MAP kinase regulates the expression of XMyf5 and affects distinct myogenic programs during Xenopus development. Dev. Biol. 288, 73-86.
17. Lee, Y. N., Gao, Y. and Wang, H. Y. (2008). Differential mediation of the Wnt canonical pathway by mammalian Dishevelleds-1, -2, and -3. Cell Signal. 20, 443-452.
18. Liu, T., Liu, X., Wang, H., Moon, R. T. and Malbon, C. C. (1999). Activation of rat frizzled-1 promotes Wnt signaling and differentiation of mouse F9 teratocarcinoma cells via pathways that require Galpha(q) and Galpha(o) function. J. Biol. Chem. 274, 33539-33544.
19. Liu, T., DeCostanzo, A. J., Liu, X., Wang, H., Hallagan, S., Moon, R. T. and Malbon, C. C. (2001). G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway. Science 292, 1718-1722.
20. Liu, T., Lee, Y. N., Malbon, C. C. and Wang, H. Y. (2002). Activation of the betacatenin/Lef-Tcf pathway is obligate for formation of primitive endoderm by mouse F9 totipotent teratocarcinoma cells in response to retinoic acid. J. Biol. Chem. 277, 30887-30891.
21. Logan, C. Y. and Nusse, R. (2004). The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810.
22. Malbon, C. C. (2005). G proteins in development. Nat. Rev. Mol. Cell. Biol. 6, 689-701.
23. Martin-Blanco, E. (2000). p38 MAPK signalling cascades: ancient roles and new functions. BioEssays 22, 637-645.
24. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O. and Clevers, H. (1996). XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86, 391-399.
25. Moon, R. T., Bowerman, B., Boutros, M. and Perrimon, N. (2002). The promise and perils of Wnt signaling through beta-catenin. Science 296, 1644-1646.
26. Moon, R. T., Kohn, A. D., De Ferrari, G. V. and Kaykas, A. (2004). WNT and betacatenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691-701.
27. Polakis, P. (2000). Wnt signaling and cancer. Genes Dev. 14, 1837-1851.
28. 2+ flux, PKC, and CamKII in vertebrate embryos. J. Cell Biol. 161, 769-777.
29. Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B. et al. (2008). Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 320, 667-670.
30. Van Lint, J., Khandelwal, R. L., Merlevede, W. and Vandenheede, J. R. (1993). A specific immunoprecipitation assay for the protein kinase FA/glycogen synthase kinase 3. Anal. Biochem. 208, 132-137.
31. Yokoyama, N., Yin, D. and Malbon, C. C. (2007). Abundance, complexation, and trafficking of Wnt/beta-catenin signaling elements in response to Wnt3a. J. Mol. Signal. 2, 11.
32. Yun, M. S., Kim, S. E., Jeon, S. H., Lee, J. S. and Choi, K. Y. (2005). Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J. Cell Sci. 118, 313-322.